FTC’s China-linked remedy-buyer stance could test line between antitrust, CFIUS
US Federal Trade Commission Chair Andrew Ferguson’s warning that he may reject a divestiture to a Chinese Communist Party-controlled buyer puts a new practical constraint on merger remedies: a buyer that...To view the full article, register now.
Already a subscriber? Click here to view full article